Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06812871
What this trial is testing

High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Sun Yat-sen University 46
Testing effectiveness (Phase 2)Looking for participantsNCT07468071
What this trial is testing

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Who this might be right for
Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung CancerAdvanced Solid Tumors Harboring the KRAS G12C Mutation
Novartis Pharmaceuticals 40
Large-scale testing (Phase 3)Study completedNCT01351116
What this trial is testing

A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy

Who this might be right for
Non-small Cell Lung Cancer
Ontario Clinical Oncology Group (OCOG) 134
Not applicableStudy completedNCT05933044
What this trial is testing

RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 662
Not applicableStudy completedNCT04281784
What this trial is testing

Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)

Who this might be right for
DementiaChronic DiseaseNeoplasm Metastasis+8 more
University of Washington 2,512
Not applicableEnded earlyNCT06192004
What this trial is testing

Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 83
Large-scale testing (Phase 3)Ended earlyNCT03516084
What this trial is testing

Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd. 185
Not applicableUnknownNCT05638269
What this trial is testing

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Who this might be right for
Essential HypertensionLiver CancerNasopharyngeal Cancer+8 more
Zhujiang Hospital 12,000
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableStudy completedNCT03429673
What this trial is testing

Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
China-Japan Friendship Hospital 10,885
Not applicableStudy completedNCT02789800
What this trial is testing

Patient-Centred Innovations for Persons With Multimorbidity - Quebec

Who this might be right for
HypertensionDepressionAnxiety+27 more
Université de Sherbrooke 284
Early research (Phase 1)Looking for participantsNCT06784193
What this trial is testing

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Olema Pharmaceuticals, Inc. 180
Large-scale testing (Phase 3)UnknownNCT00576914
What this trial is testing

Adjuvant Vinorelbine Plus Cisplatin (NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Chinese Academy of Sciences 1,108
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05359393
What this trial is testing

A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis

Who this might be right for
Advanced Rectal CancerLiver MetastasisPulmonary Metastasis+1 more
Fudan University 52
Not applicableUnknownNCT05358041
What this trial is testing

Cone Beam CT Guided Robotic Navigational Bronchoscopy

Who this might be right for
Lung NoduleLung MassLung Cancer
Columbus Regional Health 200
Not applicableStudy completedNCT06164574
What this trial is testing

Immunotherapy in Uncommon and 20ins EGFR-mut Lung Cancers

Who this might be right for
Lung Cancer
Haiquan Chen 627
Not applicableStudy completedNCT02259218
What this trial is testing

Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy

Who this might be right for
Adult Brain TumorLung CancerRadiation Toxicity
Ohio State University Comprehensive Cancer Center 273
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Testing effectiveness (Phase 2)WithdrawnNCT05465876
What this trial is testing

Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL

Who this might be right for
Chronic Lymphocytic LeukemiaCOVID-19
Sunnybrook Health Sciences Centre
Large-scale testing (Phase 3)Study completedNCT00373425
What this trial is testing

Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors

Who this might be right for
Non-small Cell Lung Cancer
OSI Pharmaceuticals 1,252
Next Page